Faculty

Institution

Unit

Venue

Robert D Cardiff

Professor Emeritus

University of California, Davis

Affiliations

School of Medicine

Pathology and Laboratory Medicine

Robert D Cardiff is currently serving as a Pathology And Laboratory Medicine Professor Emeritus at University of California, Davis.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Robert D Cardiff

University of California, Davis

Professor Emeritus

You can click a keyword to filter the displayed items

tumor biology cancer biology cancer research breast cancer molecular biology oncology genetics mammary gland mammalian biology pathology cancer genetics oncogenes cell biology medicinal research cancer cells molecular cancer carcinogenesis virus research cancer growth cancer imaging cancer genomics prostate cancer virology gene expression breast oncology vascular biology cancer care cancer discovery molecular cell biology leukemia cancer treatment tumor suppressors mouse model cancer-associated virus tumor targeting tumor heterogeneity transgenic mice cellular therapy general virology cell regulation mammary tumors mouse models cellular biology viral genetics stem cell research genitourinary cancers mammary tumorigenesis viral oncology cancer risk genome biology knockout mice signaling pathways virus structure skin cancer endocrine-related cancers human pathology molecular virology immunochemistry tumoral pathology cell proliferation anti-cancer agents intermediate host prostatic disease mammary epithelium comparative pathology human breast cancer tumor development disease progression lymphoid neoplasia prostatic intraepithelial neoplasia mammary hyperplasia growth factor prostate carcinogenesis tumor progression mice leads malignant transformation immunologic disease infectious diseases (medical specialty) medical virology

Notable Scholarly Works

Notable Federal Grants

Collaborators

Nonlinear Progression During the Occult Transition Establishes Cancer Lethality. Disease Models & Mechanisms (2025)

Joshua D. GinzelHenry ChapmanJoelle E. SillsEdwin J. AllenLawrence S. BarakRobert D. CardiffAlexander D. BorowskyHerbert Kim LyerlyBruce W. RogersJoshua C. Snyder

occult transitionbiologyoncologynonlinear progressioncancer biologycancer lethality

Abstract Lb102: Hexyl-(Cuban-1-Yl-Methyl)-Biguanide (Hcb) Suppresses N-Glycosylation of Immune Checkpoint Proteins B7-H3 and B7-H4, Reverses Tumor Hypoxia, Decreases Intratumoral Regulatory T Cells, and Increases Intratumoral Cd8+ T Cells in the Ovarian Dependent Er+Her2- Ssm2Ucd Mammary Cancer Allograft Model. Cancer Research (2023)

Zhijun GuoJianxun LeiHrishi VenkateshDavid OwenAdam BassChristine CannonJoshua McCarraBrenda KoniarCraig FloryBeverly NorrisRobert J. SchumacherSwaathi JayaramanJohn HawseEmmanuel S. AntonarakisEmanuel F. PetricoinJulia WulfkuhleRobert D. CardiffElizabeth A. AmbroseGunda I. GeorgKaylee L. SchwertfegerMichael A. FarrarBrad St. CroixMatthew P. GoetzDavid A. Potter

cell researchimmune checkpointcell biologycancer carecancer managementantioxidantscancer biologycancer researchcancer immunotherapycancer growthcancer treatmentcell regulationimmunotherapyimmunologypharmacologyoncologyclinical researchmedicinal researchcancer cellstumor hypoxia

Data From Fibroblast Growth Factor Receptor Signaling Dramatically Accelerates Tumorigenesis and Enhances Oncoprotein Translation in the Mouse Mammary Tumor Virus–Wnt-1 Mouse Model of Breast Cancer. (2023)

Adam C. PondJason I. HerschkowitzKathryn L. SchwertfegerBryan WelmYiqun ZhangBrian YorkRobert D. CardiffSusan HilsenbeckCharles M. PerouChad J. CreightonRichard E. LloydJeffrey M. Rosen

virus researchcarcinogenesisfibroblast growth factorsmetastasiscancer geneticsradiation oncologycell signalingcancer genomicsmolecular cell biologycancer imagingmolecular biologybreast canceroncogenesmedicinal researchcancer biologytumor biologyviral oncologycell biology

Supplementary Figure 5 From Her2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase. (2023)

Joshua D. GinzelChaitanya R. AcharyaVeronica LubkovHidetoshi MoriPeter G. BooneLauren K. RochelleWendy L. RobertsJeffrey I. EverittZachary C. HartmanErika J. CrosbyLawrence S. BarakMarc G. CaronJane Q. ChenNeil E. HubbardRobert D. CardiffAlexander D. BorowskyH. Kim LyerlyJoshua C. Snyder

radiation oncologycancer researchcancer imagingbreast canceroncologytumor heterogeneityoccult tumorigenic phasecancer biologytumor biology

Supplementary Tables 1-5 for Scrnaseq Marker Genes From Her2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase. (2023)

epigenomicscancer geneticscancer researchgeneticscancer genomicsbreast cancermolecular biologyoncologymedicinal researchepigeneticstumor heterogeneitycancer biologyoccult tumorigenic phasetumor biologyscrnaseq marker genes

Aberrant Androgen Action in Prostatic Progenitor Cells Induces Oncogenesis and Tumor Development Through Igf1 and Wnt Axes. Nature Communications (2022)

Won Kyung KimAdam W. OlsonJiaqi MiJinhui WangDong-Hoon LeeVien LeAlex HirotoJoseph AldahlChristian H. NenningerAlyssa J. BuckleyRobert CardiffSungyong YouZijie Sun

gametogenesiswnt axesandrologyoncogenic agentprostate cancernaturecell biologyproteomicsendocrinologynature methodmolecular cancercancer biologycancer growthtumor biologybiological engineeringcarcinogenesispharmacologyprostatic progenitor cellsoncogenesmedicinal researchaberrant androgen actiontumor development

Intratumoral in Vivo Staging of Breast Cancer by Multi-Tracer Pet and Advanced Analysis. npj Breast Cancer (2022)

Jennifer GriessingerJulian SchwabQian ChenAnna KühnJonathan CottonGregory BowdenHeike PreibschGerald ReischlLeticia Quintanilla-MartinezHidetoshi MoriAn Nguyen DangUrsula KohlhoferOlulanu H. AinaAlexander D. BorowskyBernd J. PichlerRobert D. CardiffAndreas M. Schmid

breast cancermulti-tracer pet

Physiological Expression of Pi3K H1047R Mutation Reveals Its Anti-Metastatic Potential in Erbb2-Driven Breast Cancer. Oncogene (2022)

Alexandra M. SimondTung BuiDongmei ZuoVirginie Sanguin-GendreauTrisha RaoWayne A. PhillipsRobert D. CardiffWilliam J. Muller

breast canceroncogenescancer biologyanti-metastatic potentialphysiological expression

Highly Metastatic Claudin-Low Mammary Cancers Can Originate From Luminal Epithelial Cells. Nature Communications (2021)

Patrick D. RädlerBarbara L. WehdeAleata A. TriplettHridaya ShresthaJonathan H. ShepherdAdam D. PfefferleHallgeir RuiRobert D. CardiffCharles M. PerouKay-Uwe Wagner

metastasisradiation oncologycancer researchgenitourinary cancersmammary glandoncologybreast cancerluminal epithelial cellscancer biologytumor biologybreast oncology

Abstract 3685: Sustained Ret Expression During Mammary Gland Post-Lactation Induces Premature Involution and Enhances Cancer Potential. Cancer Research (2020)

Sabrina A. ValloneMartín García SoláRobert D. CardiffRoberto P. MeissLewis A. ChodoshCarolina Shere-LevyEdith C C. KordonNancy E. HynesAlbana Gattelli

cancer researchmammary glandmolecular biologyret expressioncancer biology

1
2
3
4
5
36
10 / page

Robert D Cardiff

Professor Emeritus

University of California, Davis

Affiliations

School of Medicine

Pathology and Laboratory Medicine

Robert D Cardiff is currently serving as a Pathology And Laboratory Medicine Professor Emeritus at University of California, Davis.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Robert D Cardiff

University of California, Davis

Professor Emeritus

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Nonlinear Progression During the Occult Transition Establishes Cancer Lethality. Disease Models & Mechanisms (2025)

Joshua D. GinzelHenry ChapmanJoelle E. SillsEdwin J. AllenLawrence S. BarakRobert D. CardiffAlexander D. BorowskyHerbert Kim LyerlyBruce W. RogersJoshua C. Snyder

occult transitionbiologyoncologynonlinear progressioncancer biologycancer lethality

Adam C. PondJason I. HerschkowitzKathryn L. SchwertfegerBryan WelmYiqun ZhangBrian YorkRobert D. CardiffSusan HilsenbeckCharles M. PerouChad J. CreightonRichard E. LloydJeffrey M. Rosen

Supplementary Figure 5 From Her2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase. (2023)

radiation oncologycancer researchcancer imagingbreast canceroncologytumor heterogeneityoccult tumorigenic phasecancer biologytumor biology

Supplementary Tables 1-5 for Scrnaseq Marker Genes From Her2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase. (2023)

Aberrant Androgen Action in Prostatic Progenitor Cells Induces Oncogenesis and Tumor Development Through Igf1 and Wnt Axes. Nature Communications (2022)

Won Kyung KimAdam W. OlsonJiaqi MiJinhui WangDong-Hoon LeeVien LeAlex HirotoJoseph AldahlChristian H. NenningerAlyssa J. BuckleyRobert CardiffSungyong YouZijie Sun

Intratumoral in Vivo Staging of Breast Cancer by Multi-Tracer Pet and Advanced Analysis. npj Breast Cancer (2022)

breast cancermulti-tracer pet

Physiological Expression of Pi3K H1047R Mutation Reveals Its Anti-Metastatic Potential in Erbb2-Driven Breast Cancer. Oncogene (2022)

Alexandra M. SimondTung BuiDongmei ZuoVirginie Sanguin-GendreauTrisha RaoWayne A. PhillipsRobert D. CardiffWilliam J. Muller

breast canceroncogenescancer biologyanti-metastatic potentialphysiological expression

Highly Metastatic Claudin-Low Mammary Cancers Can Originate From Luminal Epithelial Cells. Nature Communications (2021)

Patrick D. RädlerBarbara L. WehdeAleata A. TriplettHridaya ShresthaJonathan H. ShepherdAdam D. PfefferleHallgeir RuiRobert D. CardiffCharles M. PerouKay-Uwe Wagner

metastasisradiation oncologycancer researchgenitourinary cancersmammary glandoncologybreast cancerluminal epithelial cellscancer biologytumor biologybreast oncology

Abstract 3685: Sustained Ret Expression During Mammary Gland Post-Lactation Induces Premature Involution and Enhances Cancer Potential. Cancer Research (2020)

Sabrina A. ValloneMartín García SoláRobert D. CardiffRoberto P. MeissLewis A. ChodoshCarolina Shere-LevyEdith C C. KordonNancy E. HynesAlbana Gattelli

cancer researchmammary glandmolecular biologyret expressioncancer biology

1
2
3
4
5
36
10 / page

Similar Faculty Members

Charles Eberhart

Institution

Johns Hopkins University

oncology

neurology

Mary Kay Washington, Ph.D., M.D

Institution

Vanderbilt University

immunology

gastrointestinal oncology

Timothy Scott Blackwell, M.D.

Institution

Vanderbilt University

respiratory medicine

immunology

Harold L. Moses

Institution

Vanderbilt University

oncogene

molecular cancer

Samuel French

Institution

University of California, Los Angeles

hepatology

pharmacology

Eric J. Stanbridge

Institution

University of California, Irvine

genetics

cancer biology

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene

Lorinda Chung

Institution

Stanford University

prostate cancer

urology

George Michalopoulos

Institution

University of Pittsburgh

liver regeneration

carcinogenesis

Channing Der

Institution

University of North Carolina at Chapel Hill

drug targeting

anti-cancer agent

Similar Faculty Members

Charles Eberhart

Institution

Johns Hopkins University

oncology

neurology

Mary Kay Washington, Ph.D., M.D

Institution

Vanderbilt University

immunology

gastrointestinal oncology

Timothy Scott Blackwell, M.D.

Institution

Vanderbilt University

respiratory medicine

immunology

Harold L. Moses

Institution

Vanderbilt University

oncogene

molecular cancer

Samuel French

Institution

University of California, Los Angeles

hepatology

pharmacology

Eric J. Stanbridge

Institution

University of California, Irvine

genetics

cancer biology

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene

Lorinda Chung

Institution

Stanford University

prostate cancer

urology

George Michalopoulos

Institution

University of Pittsburgh

liver regeneration

carcinogenesis

Channing Der

Institution

University of North Carolina at Chapel Hill

drug targeting

anti-cancer agent